314 related articles for article (PubMed ID: 1602398)
1. Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart.
Scott AL; Chang RS; Lotti VJ; Siegl PK
J Pharmacol Exp Ther; 1992 Jun; 261(3):931-5. PubMed ID: 1602398
[TBL] [Abstract][Full Text] [Related]
2. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.
Boulay G; Servant G; Luong TT; Escher E; Guillemette G
Mol Pharmacol; 1992 Apr; 41(4):809-15. PubMed ID: 1569928
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
Balla T; Baukal AJ; Eng S; Catt KJ
Mol Pharmacol; 1991 Sep; 40(3):401-6. PubMed ID: 1654513
[TBL] [Abstract][Full Text] [Related]
4. Characterization of renal angiotensin II receptors using subtype selective antagonists.
Edwards RM; Stack EJ; Weidley EF; Aiyar N; Keenan RM; Hill DT; Weinstock J
J Pharmacol Exp Ther; 1992 Mar; 260(3):933-8. PubMed ID: 1545405
[TBL] [Abstract][Full Text] [Related]
5. Characterization of PD 121981- and CGP 42112-induced unmasking of low concentration effects of angiotensin II in rabbit abdominal aorta.
Hong KW; Rhim BY; Shin YW; Yoo SE
J Pharmacol Exp Ther; 1994 Dec; 271(3):1591-6. PubMed ID: 7996473
[TBL] [Abstract][Full Text] [Related]
6. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB
J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
[TBL] [Abstract][Full Text] [Related]
7. [Angiotensin receptors in the rat myocardium during pre- and postnatal development].
Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
Cardiologia; 1993 Jul; 38(7):471-6. PubMed ID: 8221742
[TBL] [Abstract][Full Text] [Related]
8. Characterization of putative glomerular receptors for angiotensin II in the rainbow trout Oncorhynchus mykiss using the antagonists Losartan, PD 123177, and saralasin.
Cobb CS; Brown JA
Gen Comp Endocrinol; 1993 Oct; 92(1):123-31. PubMed ID: 8262354
[TBL] [Abstract][Full Text] [Related]
9. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors].
Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
Cardiologia; 1993 Aug; 38(8):519-23. PubMed ID: 8313407
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor subtypes in bovine and human ventricular myocardium.
Nozawa Y; Haruno A; Oda N; Yamasaki Y; Matsuura N; Yamada S; Inabe K; Kimura R; Suzuki H; Hoshino T
J Pharmacol Exp Ther; 1994 Aug; 270(2):566-71. PubMed ID: 8071849
[TBL] [Abstract][Full Text] [Related]
11. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
12. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
Wong PC; Timmermans PB
J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
[TBL] [Abstract][Full Text] [Related]
13. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.
Chang RS; Lotti VJ
Mol Pharmacol; 1990 Mar; 37(3):347-51. PubMed ID: 2314387
[TBL] [Abstract][Full Text] [Related]
14. Characterization of glomerular angiotensin II receptor subtypes.
Gauquelin G; Garcia R
Receptor; 1992; 2(3):207-12. PubMed ID: 1472951
[TBL] [Abstract][Full Text] [Related]
15. Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands.
Keiser JA; Bjork FA; Hodges JC; Taylor DG
J Pharmacol Exp Ther; 1992 Sep; 262(3):1154-60. PubMed ID: 1527720
[TBL] [Abstract][Full Text] [Related]
16. Subclasses of angiotensin II binding sites and their functional significance.
Dudley DT; Panek RL; Major TC; Lu GH; Bruns RF; Klinkefus BA; Hodges JC; Weishaar RE
Mol Pharmacol; 1990 Sep; 38(3):370-7. PubMed ID: 2402226
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB
J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor subtypes and biological responses in the rat heart.
Feolde E; Vigne P; Frelin C
J Mol Cell Cardiol; 1993 Nov; 25(11):1359-67. PubMed ID: 8301669
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
le Tran Y; Forster C
Can J Physiol Pharmacol; 1996 Dec; 74(12):1277-86. PubMed ID: 9047036
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II binding sites in the rat fetus: characterization of receptor subtypes and interaction with guanyl nucleotides.
Feuillan PP; Millan MA; Aguilera G
Regul Pept; 1993 Mar; 44(2):159-69. PubMed ID: 8469771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
